Roth Capital Starts Seelos Therapeutics (SEEL) at Buy

May 14, 2019 7:26 AM EDT Send to a Friend
Roth Capital analyst Yasmeen Rahimi initiates coverage on Seelos ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login